Adherence to varenicline in the COMPASS smoking cessation intervention trial.

ABSTRACT:

Introduction

Patient adherence to smoking cessation medications can impact their effectiveness. It is important to understand the extent to which prescribed medications are actually taken by smokers, how this influences smoking cessation outcomes, and what factors may influence adherence.

Methods

Smokers recruited from a large health plan were randomized to receive different modes of cessation counseling in combination with varenicline (Swan, G. E., McClure, J. B., Jack, L. M., Zbikowski, S. M., Javitz, H. S., Catz, S. L., et al. 2010.Behavioral counseling and varenicline treatment for smoking cessation. American Journal of Preventive Medicine, 38, 482-490). One thousand one hundred and sixty-one participants were mailed a 28-day varenicline supply when they set a quit date

SUBMITTER: Catz SL 

PROVIDER: S-EPMC3082504 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature